-
Family Behind Oxycontin Denies Any Responsibility for Opioid Crisis
drugs
August 20, 2021
The former president and co-chairman of Purdue Pharma said Wednesday that his family and the company bear no responsibility for the opioid crisis in the United States.
-
Purdue Pharma pleads guilty to three criminal charges
pharmaceutical-technology
November 26, 2020
Opioid maker Purdue Pharma has pleaded guilty in federal court in Newark, New Jersey, to criminal charges over the handling of its OxyContin painkiller drug.
-
Purdue Files for Bankruptcy Over Opioid Crisis Suits
drugs
September 17, 2019
OxyContin maker Purdue Pharma has filed for Chapter 11 bankruptcy, touching off what could be a fierce battle by dozens of states hoping to recoup billions spent fighting the opioid crisis.
-
Purdue Pharma Tentatively Reaches Settlement in Opioid Lawsuits
drugs
September 12, 2019
OxyContin maker Purdue Pharma has reached a tentative settlement with a coalition of states and local governments that sued the company over its role in America's ongoing opioid crisis, press reports say.
-
Opioid Maker Purdue Pharma Expected to File for Bankruptcy
drugs
September 10, 2019
Settlement talks with OxyContin maker Purdue Pharma over its role in the U.S. opioid crisis have reached a stalemate and the company is expected to file for bankruptcy...
-
OxyContin Maker Offers Up to $12 Billion to Settle Opioid Claims
drugs
August 28, 2019
Purdue Pharma, the drug giant many have blamed for the ongoing U.S. opioid abuse crisis, has offered $10 billion to $12 billion to settle more than 2,000 lawsuits lodged against it, NBC News is reporting.
-
After Oklahoma payout, Purdue faces 5 new state lawsuits over OxyContin
fiercepharma
May 21, 2019
Purdue Pharma and its founding family took a quarter-of-a-billion-dollar hit when it settled with the state of Oklahoma over a lawsuit accusing the company of pushing false and misleading ads for powerful opioid OxyContin.
-
Opioid Rxs Decreasing, But Not for All Doctors
drugs
March 14, 2019
Doctors may be pulling out their prescription pads less often for opioid medications, but not everyone's on the same page yet.